Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Chrysoula BoutariChristos V RizosMichalis DoumasGeorge LiamisIoannis SkoumasLoukianos S RallidisAnastasia GaroufiGenovefa KolovouKonstantinos TziomalosEmmanouil SkalidisVasileios KotsisGeorge SfikasVaia LambadiariPanagiotis AnagnostisEleni BilianouGeorgia AnastasiouIosif KoutagiarEstela KiouriAchilleas AttilakosVana KolovouEvangelos ZacharisChristina AntzaEvangelos N LiberopoulosPublished in: Pharmaceuticals (Basel, Switzerland) (2022)
Familial hypercholesterolemia (FH) and type 2 diabetes mellitus (T2DM) are both associated with a high risk of atherosclerotic cardiovascular disease (ASCVD). Little is known about the prevalence of T2DM and its association with ASCVD risk in FH patients. This was a cross-sectional analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH) including adults with FH (n = 1719, mean age 51.3 ± 14.6 years). Of FH patients, 7.2% had a diagnosis of T2DM. The prevalence of ASCVD, coronary artery disease (CAD), and stroke was higher among subjects with T2DM compared with those without (55.3% vs. 23.3%, 48.8% vs. 20.7%, 8.3% vs. 2.7%, respectively, p < 0.001). When adjusted for age, systolic blood pressure, smoking, body mass index, hypertension, waist circumference, triglyceride levels, high-density lipoprotein cholesterol levels, and gender, T2DM was significantly associated with prevalent ASCVD [OR 2.0 (95% CI 1.2-3.3), p = 0.004]. FH patients with T2DM were more likely to have undergone coronary revascularization than those without (14.2% vs. 4.5% for coronary artery bypass graft, and 23.9% vs. 11.5% for percutaneous coronary intervention, p < 0.001). T2DM is associated with an increased risk for prevalent ASCVD in subjects with FH. This may have implications for risk stratification and treatment intensity in these patients.
Keyphrases
- coronary artery disease
- cardiovascular disease
- body mass index
- blood pressure
- percutaneous coronary intervention
- end stage renal disease
- ejection fraction
- glycemic control
- type diabetes
- newly diagnosed
- chronic kidney disease
- prognostic factors
- heart failure
- peritoneal dialysis
- atrial fibrillation
- coronary artery bypass grafting
- cardiovascular events
- physical activity
- acute coronary syndrome
- metabolic syndrome
- weight loss
- insulin resistance
- blood brain barrier
- patient reported outcomes
- adipose tissue
- blood glucose
- aortic stenosis
- subarachnoid hemorrhage